Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1966 Nov 30;124(6):1135–1151. doi: 10.1084/jem.124.6.1135

ANTIGENICITY OF THE M PROTEINS OF GROUP A HEMOLYTIC STREPTOCOCCI

III. ANTIBODY RESPONSES AND CUTANEOUS HYPERSENSITIVITY IN HUMANS

Eugene N Fox 1, M K Wittner 1, Albert Dorfman 1
PMCID: PMC2138333  PMID: 5925319

Abstract

Highly purified M proteins were used for determining cutaneous hypersensitivity and type-specific circulating antibodies in normal adults and infants. 80% of 91 adults and 8% of 59 infants exhibited a transient delayed cutaneous reaction to at least two of types 12, 14, and 24 M proteins. Antibodies assayed by passive hemagglutination were observed in 90% of the adults and 13% of the infants. Vaccines of 10 µg of alum-precipitated M protein or 20 µg of the soluble antigen were administered to adults not exhibiting delayed hypersensitivity. Within 2 wk hemagglutination liters increased significantly in 31 of 33 subjects. Preimmunization antibody levels indicated that these responses were probably anamnestic reactions from previous exposures to homologous serotypes of group A streptococci. Sera exhibiting large increments in antibody titers resulting from M protein inoculations also had type-specific bactericidal properties. "Attenuated" M proteins, produced by partial degradation with trypsin induced only minimal cutaneous reactions in hypersensitive adults, but still retained most of the antigenic specificity when assayed in vitro and in vivo. The utility of M protein vaccines for human use is discussed in reference to the low incidence of cutaneous hypersensitivity in infants, the potentials of polyvalent attenuated M protein vaccines and the apparent absence of immune cross-reactivity between pure M proteins and human heart and kidney tissues.

Full Text

The Full Text of this article is available as a PDF (960.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. FOX E. N. ANTIGENICITY OF THE M PROTEINS OF GROUP A HEMOLYTIC STREPTOCOCCI. J Immunol. 1964 Nov;93:826–837. [PubMed] [Google Scholar]
  2. Fox E. N., Wittner M. K. The multiple molecular structure of the M proteins of group A streptococci. Proc Natl Acad Sci U S A. 1965 Oct;54(4):1118–1125. doi: 10.1073/pnas.54.4.1118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. KAPLAN M. H., MEYESERIAN M. An immunological cross-reaction between group-A streptococcal cells and human heart tissue. Lancet. 1962 Apr 7;1(7232):706–710. doi: 10.1016/s0140-6736(62)91653-7. [DOI] [PubMed] [Google Scholar]
  4. KAPLAN M. H., SUCHY M. L. IMMUNOLOGIC RELATION OF STREPTOCOCCAL AND TISSUE ANTIGENS. II. CROSS-REACTION OF ANTISERA TO MAMMALIAN HEART TISSUE WITH A CELL WALL CONSTITUENT OF CERTAIN STRAINS OF GROUP A STREPTOCOCCI. J Exp Med. 1964 Apr 1;119:643–650. doi: 10.1084/jem.119.4.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. LANCEFIELD R. C. Current knowledge of type-specific M antigens of group A streptococci. J Immunol. 1962 Sep;89:307–313. [PubMed] [Google Scholar]
  6. LANCEFIELD R. C. Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J Exp Med. 1957 Oct 1;106(4):525–544. doi: 10.1084/jem.106.4.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. LAWRENCE H. S. The cellular transfer in humans of delayed cutaneous reactivity to hemolytic streptococci. J Immunol. 1952 Feb;68(2):159–178. [PubMed] [Google Scholar]
  8. LEWIS U. J., CLARK M. O. PREPARATIVE METHODS FOR DISK ELECTROPHORESIS WITH SPECIAL REFERENCE TO THE ISOLATION OF PITUITARY HORMONES. Anal Biochem. 1963 Oct;6:303–315. doi: 10.1016/0003-2697(63)90154-4. [DOI] [PubMed] [Google Scholar]
  9. MARKOWITZ A. S., LANGE C. F., Jr STREPTOCOCCAL RELATED GLOMERULONEPHRITIS. I. ISOLATION, IMMUNOCHEMISTRY AND COMPARATIVE CHEMISTRY OF SOLUBLE FRACTIONS FROM TYPE 12 NEPHRITOGENIC STREPTOCOCCI AND HUMAN GLOMERULI. J Immunol. 1964 Apr;92:565–575. [PubMed] [Google Scholar]
  10. POTTER E. V., STOLLERMAN G. H., SIEGEL A. C. Recall of type specific antibodies in man by injections of streptococcal cell walls. J Clin Invest. 1962 Feb;41:301–310. doi: 10.1172/JCI104483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. RAFFEL S., NEWEL J. M. The delayed hypersensitivity induced by antigen-antibody complexes. J Exp Med. 1958 Dec 1;108(6):823–841. doi: 10.1084/jem.108.6.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. SCHMIDT W. C. Type-specific antibody formation in man following injection of streptococcal M protein. J Infect Dis. 1960 May-Jun;106:250–255. doi: 10.1093/infdis/106.3.250. [DOI] [PubMed] [Google Scholar]
  13. STOLLERMAN G. H., KANTOR F. S., GORDON B. D. Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. I. A typical behavior of some human and rabbit bloods. J Exp Med. 1958 Oct 1;108(4):475–491. doi: 10.1084/jem.108.4.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Schwab J. H. Biological properties of streptococcal cell-wall particles. I. Determinants of the chronic nodular lesion of connective tissue. J Bacteriol. 1965 Nov;90(5):1405–1411. doi: 10.1128/jb.90.5.1405-1411.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Swift H. F., Wilson A. T., Lancefield R. C. TYPING GROUP A HEMOLYTIC STREPTOCOCCI BY M PRECIPITIN REACTIONS IN CAPILLARY PIPETTES. J Exp Med. 1943 Aug 1;78(2):127–133. doi: 10.1084/jem.78.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. WOLFE C. K., Jr, HAYASHI J. A., WALSH G., BARKULIS S. S. Type-specific antibody response in man to injections of cell walls and M protein from group A, type 14 streptococci. J Lab Clin Med. 1963 Mar;61:459–468. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES